Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCHE | P06276 | 1/20 | 0.86 |
| ▸ | DDAH1 | O94760 | 1/20 | 0.63 |
| ▸ | POLB | P06746 | 1/20 | 0.63 |
| ▸ | GAA | P10253 | 1/20 | 0.59 |
| ▸ | NPC1 | O15118 | 4/20 | 0.58 |
| ▸ | RAB9A | P51151 | 4/20 | 0.58 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.56 |
| ▸ | PKM | P14618 | 1/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.54 |
| ▸ | TP53 | P04637 | 1/20 | 0.54 |
| ▸ | TSHR | P16473 | 1/20 | 0.54 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.54 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.54 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.54 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.54 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.54 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL370724 | 1.00 | BCHE (0.86) | BCHEDDAH1POLBGAANPC1 | |
| Magnesium SCHEMBL30119882 | 0.98 | BCHE (0.83) | BCHEDDAH1POLBGAANPC1 | |
| SCHEMBL5609299 | 0.93 | BCHE (0.75) | BCHEDDAH1POLBGAANPC1 | |
| SCHEMBL8201381 | 0.92 | BCHE (1.00) | BCHEDDAH1POLBGAANPC1 | |
| SCHEMBL707879 | 0.91 | BCHE (0.73) | BCHEDDAH1POLBGAANPC1 | |
| SCHEMBL10144030 | 0.89 | BCHE (0.75) | BCHEDDAH1POLBGAANPC1 | |
| SCHEMBL20677816 | 0.89 | BCHE (0.87) | BCHEDDAH1POLBGAANPC1 | |
| SCHEMBL20677807 | 0.89 | BCHE (0.87) | BCHEDDAH1POLBGAANPC1 | |
| Hydrochloric Acid SCHEMBL710645 | 0.88 | BCHE (0.69) | BCHEDDAH1POLBGAANPC1 | |
| Hydrochloric Acid SCHEMBL710646 | 0.88 | BCHE (0.69) | BCHEDDAH1POLBGAANPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250009917-A1 | MACROCYCLE CONTAINING COMPOUNDS AND RADIOLABELLED COMPLEXES THEREOF, AS LIGANDS IN TARGETED RADIOTHERAPY APPLICATIONS | THE UNIVERSITY OF MELBOURNE (AU) | 2025-01-09 | — | — | US | claimed |
| EP-4408839-A1 | MACROCYCLE CONTAINING COMPOUNDS AND RADIOLABELLED COMPLEXES THEREOF, AS LIGANDS IN TARGETED RADIOTHERAPY APPLICATIONS | The University of Melbourne (AU) | 2024-08-07 | — | — | EP | claimed |
| WO-2023049963-A1 | MACROCYCLE CONTAINING COMPOUNDS AND RADIOLABELLED COMPLEXES THEREOF, AS LIGANDS IN TARGETED RADIOTHERAPY APPLICATIONS | THE UNIVERSITY OF MELBOURNE (AU) | 2023-04-06 | — | — | WO | claimed |
| US-20250359553-A1 | METAL COMPLEXES FOR PROMOTING GROWTH IN A PHOTOSYNTHETIC ORGANISM | IMPERIAL COLLEGE INNOVATIONS LTD (GB) | 2025-11-27 | — | — | US | disclosed |
| US-12448612-B2 | Mutant polymerases and methods of using the same | THERMO FISHER SCIENTIFIC BALTICS UAB (LT) | 2025-10-21 | — | — | US | disclosed |
| US-12402627-B2 | Metal complexes for promoting growth in a photosynthetic organism | IMPERIAL COLLEGE INNOVATIONS LIMITED (GB) | 2025-09-02 | — | — | US | disclosed |
| US-20250009917-A1 | MACROCYCLE CONTAINING COMPOUNDS AND RADIOLABELLED COMPLEXES THEREOF, AS LIGANDS IN TARGETED RADIOTHERAPY APPLICATIONS | THE UNIVERSITY OF MELBOURNE (AU) | 2025-01-09 | — | — | US | disclosed |
| US-20240287502-A1 | OLIGONUCLEOTIDE-TETHERED NUCLEOTIDES | THERMO FISHER SCIENTIFIC BALTICS UAB (LT) | 2024-08-29 | — | — | US | disclosed |
| EP-4408839-A1 | MACROCYCLE CONTAINING COMPOUNDS AND RADIOLABELLED COMPLEXES THEREOF, AS LIGANDS IN TARGETED RADIOTHERAPY APPLICATIONS | The University of Melbourne (AU) | 2024-08-07 | — | — | EP | disclosed |
| US-20240102003-A1 | OLIGONUCLEOTIDE-TETHERED NUCLEOTIDES | THERMO FISHER SCIENTIFIC BALTICS UAB (LT) | 2024-03-28 | — | — | US | disclosed |
| US-11739316-B2 | Oligonucleotide-tethered nucleotides | THERMO FISHER SCIENTIFIC BALTICS UAB (LT) | 2023-08-29 | — | — | US | disclosed |
| US-20230174957-A1 | MUTANT POLYMERASES AND METHODS OF USING THE SAME | THERMO FISHER SCIENTIFIC BALTICS UAB (LT) | 2023-06-08 | — | — | US | disclosed |
| WO-2023049963-A1 | MACROCYCLE CONTAINING COMPOUNDS AND RADIOLABELLED COMPLEXES THEREOF, AS LIGANDS IN TARGETED RADIOTHERAPY APPLICATIONS | THE UNIVERSITY OF MELBOURNE (AU) | 2023-04-06 | — | — | WO | disclosed |
| EP-4150067-A2 | MUTANT POLYMERASES AND METHODS OF USING THE SAME | THERMO FISHER SCIENTIFIC BALTICS UAB (LT) | 2023-03-22 | — | — | EP | disclosed |
| EP-3617314-B1 | OLIGONUCLEOTIDE DERIVATIVE OR SALT THEREOF | KYOWA KIRIN CO LTD (JP) | 2023-02-15 | — | — | EP | disclosed |
| EP-3529380-B1 | METHODS FOR CHEMICAL LIGATION OF NUCLEIC ACIDS | ILLUMINA INC (US) | 2022-06-29 | — | — | EP | disclosed |
| EP-3986907-A1 | OLIGONUCLEOTIDE-TETHERED TRIPHOSPHATE NUCLEOTIDES USEFUL FOR LABELLING NUCLEIC ACIDS FOR PREPARING NEXT-GENERATION SEQUENCING LIBRARIES | Thermo Fisher Scientific Baltics UAB (LT) | 2022-04-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250359553-A1 | METAL COMPLEXES FOR PROMOTING GROWTH IN A PHOTOSYNTHETIC ORGANISM | SOD1, PPOX, MAX | BCHE 3227/4885DDAH1 2322/4885POLB 1035/4885 |
| US-12402627-B2 | Metal complexes for promoting growth in a photosynthetic organism | PPOX, SOD1, MAX | BCHE 3169/4885DDAH1 2252/4885POLB 991/4885 |
| US-20250009917-A1 | MACROCYCLE CONTAINING COMPOUNDS AND RADIOLABELLED COMPLEXES THEREOF, AS LIGANDS IN TARGETED RADIOTHERAPY APPLICATIONS | CCR3, CBR3, HRH3 | BCHE 2168/4885DDAH1 1893/4885POLB 1223/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.